MedPath

Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB echo and Black Blood MRI

Not Applicable
Conditions
Carotid artery stenosis
Registration Number
JPRN-UMIN000001114
Lead Sponsor
Gifu University Graduate School of Medicine Department of Neurosurgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with a history of adverse effects or allergy to atorvastatin 2) Patients with a history of angina or miocardial infarction 3) Patients parformed carotid endartelectomy or carotid artery stenting before the entry of the study 4) Patients who are pregnant, possibly pregnant, or lactating 5) Patients judged inappropriate for this study by a physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The property change in carotid artery plaque after three and six months using IB echo and Black Blood MRI.
Secondary Outcome Measures
NameTimeMethod
1) The change of the serum lipid metabolism in six months: Serum total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides 2) The change of the inflammatory marker in six months: serum high sensitivity CRP 3) Ischemic attack in the territory of the internal carotid artery on the ipsilateral side
© Copyright 2025. All Rights Reserved by MedPath